Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.
Check against the official notice below — it lists the full affected range.
SigmaPharm Laboratories LLC is recalling four lots of Liothyronine Sodium Tablets, USP 5 mcg in 100-count and 1000-count bottles due to potential carryover of trace amounts of a previously manufactured product. The affected lots are: 1302201 (expires 01/2015), 1305501 (expires 03/2015), 1314801 (expires 10/2015), and 1302202 (expires 01/2015). A total of 43,007 bottles have been distributed nationwide and in Puerto Rico.
The source document does not specify a remedy or recommended action for affected consumers.
Written by software from the official notice below. Not reviewed by a lawyer.
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Reason for recall: Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product. Distribution: Nationwide and Puerto Rico Quantity: 43,007 Bottles Lot/code info: Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.